|
WO2017021974A2
|
|
Synergistic composition of lecithin and lysolecithin for improving bioavailability and solubility of hydrophobic compounds and extracts
|
|
US2016015813A1
|
|
Novel and synergistic composition of lecithin and lysolecithin for improving bioavailability and solubility of hydrophobic compounds and extracts
|
|
WO2015186144A2
|
|
Method of inhibition of beta-secretase by using bis-o-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases
|
|
AU2013264767A1
|
|
Novel highly bioavailable, water soluble and sustained release nanoformulations of hydrophobic plant derived compounds and extracts
|
|
AU2011232745A1
|
|
Curcuminoids and its metabolites for the application in allergic nasal conditions
|
|
WO2010109482A2
|
|
Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions
|
|
CN102215856A
|
|
Topical formulation(s) for treatment of inflammation, skin and mucosal disorders and other diseases thereof
|
|
CN102202652A
|
|
A process for nanoemulsification of curcumin and derivatives of curcumin
|
|
AU2009329024A1
|
|
Curcuminoids and its metabolites for the application in ocular diseases
|
|
CN102131765A
|
|
Orally active curcuminoid compounds
|
